Your browser doesn't support javascript.
loading
Correction to: Glycogen synthase kinase 3 beta inhibitor SB216763 improves Kir2.1 expression after myocardia infraction in rats.
Chang, Cheng; Wang, Shu-Hui; Xu, Li-Na; Su, Xue-Ling; Zeng, Yi-Fan; Wang, Peng; Zhang, Li-Rong; Han, Sheng-Na.
Afiliação
  • Chang C; Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China.
  • Wang SH; Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China.
  • Xu LN; Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China.
  • Su XL; Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China.
  • Zeng YF; Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China.
  • Wang P; Basic Medical Department, School of Nursing, Zhengzhou University, Zhengzhou, 450001, China.
  • Zhang LR; Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China.
  • Han SN; Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China. hanshengna@126.com.
J Interv Card Electrophysiol ; 63(2): 249-250, 2022 Mar.
Article em En | MEDLINE | ID: mdl-35080733

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article